{"id":28140,"date":"2026-02-07T09:42:54","date_gmt":"2026-02-07T09:42:54","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/decentralized-clinical-trials-market-mordor\/"},"modified":"2026-09-18T19:36:34","modified_gmt":"2026-09-18T10:36:34","slug":"decentralized-clinical-trials-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/decentralized-clinical-trials-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/decentralized-clinical-trials-market-1750086030207-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/decentralized-clinical-trials-market-size-image-1768489222705.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc6d0\uaca9 \uc758\ub8cc \ubc0f \uc6d0\uaca9 \ud658\uc790 \ubaa8\ub2c8\ud130\ub9c1 \uc778\ud504\ub77c \ud655\uc7a5<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc785\uc99d\ub41c \ud6a8\uc728\uc131 \ud5a5\uc0c1 \ubc0f \uc5f0\uad6c \uae30\uac04 \ub2e8\ucd95<\/li>\n<li class=\"toc-level-3\">4.2.3 \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \ubaa8\ub378\uc5d0 \ub300\ud55c \uae00\ub85c\ubc8c \uaddc\uc81c \uc2b9\uc778 \uac15\ud654<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc5f0\uacb0\ub41c \uc6e8\uc5b4\ub7ec\ube14 \ubc0f \ubc14\uc774\uc624\uc13c\uc11c \uae30\uc220\uc758 \ud655\uc0b0<\/li>\n<li class=\"toc-level-3\">4.2.5 AI \uae30\ubc18 \ud569\uc131 \ub300\uc870\uad70 \ubc0f \uc608\uce21 \ubd84\uc11d\uc758 \ub4f1\uc7a5<\/li>\n<li class=\"toc-level-3\">4.2.6 \ube14\ub85d\uccb4\uc778 \uae30\ubc18 \ub3d9\uc758 \ubc0f \ub370\uc774\ud130 \ubb34\uacb0\uc131 \uc194\ub8e8\uc158 \ucc44\ud0dd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc870\ud654\ub41c \uad6d\uc81c \ub370\uc774\ud130 \uac70\ubc84\ub10c\uc2a4 \ud504\ub808\uc784\uc6cc\ud06c \ubd80\uc871<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc99d\uac00\ud558\ub294 \uc0ac\uc774\ubc84 \ubcf4\uc548 \ubc0f \uac1c\uc778 \uc815\ubcf4 \ubcf4\ud638 \uaddc\uc815 \uc900\uc218 \uc704\ud5d8<\/li>\n<li class=\"toc-level-3\">4.3.3 \uace0\ub839 \ubc0f \uc18c\uc678\ub41c \ud658\uc790 \uc9d1\ub2e8 \uac04 \uae30\uc220 \uc811\uadfc\uc131 \uaca9\ucc28<\/li>\n<li class=\"toc-level-3\">4.3.4 \uac00\uc815 \uae30\ubc18 \uac80\uccb4 \ucc44\ucde8\uc5d0 \ub300\ud55c \ubbf8\ud574\uacb0\ub41c \uc0c1\ud658 \ubc0f \ubb3c\ub958 \ubb38\uc81c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.5.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc5f0\uad6c \uc124\uacc4\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc911\uc7ac\uc801<\/li>\n<li class=\"toc-level-3\">5.1.2 \uad00\ucc30\uc801<\/li>\n<li class=\"toc-level-3\">5.1.3 \ud655\ub300 \uc811\uadfc<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uad6c\uc131 \uc694\uc18c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ud074\ub77c\uc6b0\ub4dc \uae30\ubc18 \ud50c\ub7ab\ud3fc<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc6f9 \uae30\ubc18 \ud50c\ub7ab\ud3fc<\/li>\n<li class=\"toc-level-3\">5.2.3 \ud558\uc774\ube0c\ub9ac\ub4dc \/ \uc571 \uc911\uc2ec \ud50c\ub7ab\ud3fc<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uce58\ub8cc \uc801\uc6a9\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc885\uc591\ud559<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc2ec\uc7a5\ud559<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc2e0\uacbd\ud559<\/li>\n<li class=\"toc-level-3\">5.3.4 \ud638\ud761\uae30<\/li>\n<li class=\"toc-level-3\">5.3.5 \uae30\ud0c0 \uce58\ub8cc \uc801\uc6a9<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uc81c\uc57d &amp; \uc0dd\uba85\uacf5\ud559 \uc2a4\ud3f0\uc11c<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc758\ub8cc\uae30\uae30 \uc81c\uc870\uc5c5\uccb4<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc784\uc0c1\uc2dc\ud5d8\uc218\ud0c1\uae30\uad00 (CRO)<\/li>\n<li class=\"toc-level-3\">5.4.4 \ud559\uc220 &amp; \uc5f0\uad6c \uae30\uad00<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uc720\ub7fd \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74 \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \ub0a8\ubbf8 \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \ud68c\uc0ac \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Advarra<\/li>\n<li class=\"toc-level-3\">6.3.2 Thermo Fisher Scientific (\uc784\uc0c1 \uc5f0\uad6c \uadf8\ub8f9)<\/li>\n<li class=\"toc-level-3\">6.3.3 IQVIA Inc.<\/li>\n<li class=\"toc-level-3\">6.3.4 Dassault Syst\u00e8mes<\/li>\n<li class=\"toc-level-3\">6.3.5 Clario<\/li>\n<li class=\"toc-level-3\">6.3.6 ProPharma<\/li>\n<li class=\"toc-level-3\">6.3.7 Obvio Health<\/li>\n<li class=\"toc-level-3\">6.3.8 Oracle (\ud5ec\uc2a4 \uc0ac\uc774\uc5b8\uc2a4)<\/li>\n<li class=\"toc-level-3\">6.3.9 Veristat<\/li>\n<li class=\"toc-level-3\">6.3.10 Everest Global<\/li>\n<li class=\"toc-level-3\">6.3.11 Curavit<\/li>\n<li class=\"toc-level-3\">6.3.12 Curebase<\/li>\n<li class=\"toc-level-3\">6.3.13 Florence Healthcare<\/li>\n<li class=\"toc-level-3\">6.3.14 ICON plc<\/li>\n<li class=\"toc-level-3\">6.3.15 Labcorp Drug Development<\/li>\n<li class=\"toc-level-3\">6.3.16 Parexel<\/li>\n<li class=\"toc-level-3\">6.3.17 Syneos Health<\/li>\n<li class=\"toc-level-3\">6.3.18 Signant Health<\/li>\n<li class=\"toc-level-3\">6.3.19 Science 37<\/li>\n<li class=\"toc-level-3\">6.3.20 Medable<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8(Decentralized Clinical Trials, DCT) \uc2dc\uc7a5\uc740 2026\ub144 107\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 210\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub418\uba70, 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 14.42%\ub97c \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4. \uc774\ub294 2025\ub144 93\uc5b5 9\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c \uc9c0\uc18d\uc801\uc73c\ub85c \uc131\uc7a5\ud558\ub294 \ucd94\uc138\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \ud604\uc7a5 \uc911\uc2ec\uc758 \uc5f0\uad6c \ubaa8\ub378\uc5d0\uc11c \uae30\uc220 \uae30\ubc18\uc758 \ud658\uc790 \uc911\uc2ec \ubaa8\ub378\ub85c\uc758 \uacb0\uc815\uc801\uc778 \uc804\ud658\uc744 \ubc18\uc601\ud558\uba70, \uc811\uadfc\uc131\uc744 \ud655\ub300\ud558\uace0 \ub370\uc774\ud130 \ubb34\uacb0\uc131\uc744 \ud5a5\uc0c1\uc2dc\ud0a4\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc73c\ub85c \ud3c9\uac00\ub429\ub2c8\ub2e4.<\/p>\n<p>\ud575\uc2ec \ubcf4\uace0\uc11c \uc694\uc57d<br \/>\n*   \uc5f0\uad6c \uc124\uacc4\ubcc4: 2025\ub144 \uae30\uc900 \uc911\uc7ac\uc801 \uc784\uc0c1\uc2dc\ud5d8\uc774 63.21%\uc758 \ub9e4\ucd9c \uc810\uc720\uc728\ub85c \uc2dc\uc7a5\uc744 \uc8fc\ub3c4\ud588\uc73c\uba70, \ud655\ub300 \uc811\uadfc \uc784\uc0c1\uc2dc\ud5d8\uc740 2031\ub144\uae4c\uc9c0 15.89%\uc758 CAGR\ub85c \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uad6c\uc131 \uc694\uc18c\ubcc4: 2025\ub144 \ud074\ub77c\uc6b0\ub4dc \ud50c\ub7ab\ud3fc\uc774 \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 57.64%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \ud558\uc774\ube0c\ub9ac\ub4dc\/\uc571 \uc911\uc2ec \uc194\ub8e8\uc158\uc740 2031\ub144\uae4c\uc9c0 16.48%\uc758 CAGR\ub85c \ud655\uc7a5\ub420 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \ubd84\uc57c\ubcc4: 2025\ub144 \uc885\uc591\ud559\uc774 \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5 \uaddc\ubaa8\uc758 45.72%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc2e0\uacbd\ud559\uc740 2031\ub144\uae4c\uc9c0 16.02%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: 2025\ub144 \uc81c\uc57d \ubc0f \ubc14\uc774\uc624\ud14d \uc2a4\ud3f0\uc11c\uac00 56.98%\uc758 \uc810\uc720\uc728\uc744 \uae30\ub85d\ud588\uc73c\uba70, \uc758\ub8cc\uae30\uae30 \uc81c\uc870\uc5c5\uccb4\ub294 16.87%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc744 \ubcf4\uc600\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: 2025\ub144 \ubd81\ubbf8\uac00 48.12%\uc758 \uc810\uc720\uc728\ub85c \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud588\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2031\ub144\uae4c\uc9c0 15.32%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed\uc73c\ub85c \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825 (\uc131\uc7a5 \ub3d9\uc778)<br \/>\n\ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \ub3d9\uc778\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc6d0\uaca9 \uc758\ub8cc \ubc0f \uc6d0\uaca9 \ud658\uc790 \ubaa8\ub2c8\ud130\ub9c1 \uc778\ud504\ub77c \ud655\uc7a5 (CAGR\uc5d0 2.8% \uae30\uc5ec): \ud32c\ub370\ubbf9 \uae30\uac04 \ub3d9\uc548 \uae09\uc99d\ud55c \uc6d0\uaca9 \uc758\ub8cc \uc0ac\uc6a9\uc740 \ub300\uaddc\ubaa8 \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8\uc758 \uae30\ubc18\uc744 \uc81c\uacf5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uba54\ub514\ucf00\uc5b4\uc758 \uc6d0\uaca9 \ubaa8\ub2c8\ud130\ub9c1 \ucf54\ub4dc \uc0c1\ud658, 5G \ubc0f \uc800\ube44\uc6a9 \uc6e8\uc5b4\ub7ec\ube14 \uae30\uae30 \ud655\uc0b0, AI \uae30\ubc18 \ubd84\uc11d\uc740 \uc9c0\uc18d\uc801\uc778 \uc0dd\uccb4 \ub370\uc774\ud130 \ud68d\ub4dd\uc744 \uac00\ub2a5\ud558\uac8c \ud558\uba70, \uc758\ub8cc \uac1c\uc785 \uc18d\ub3c4\ub97c \ub192\uc774\uace0 \uc18c\uc678 \uc9c0\uc5ed\uc758 \uc784\uc0c1\uc2dc\ud5d8 \uc811\uadfc\uc131\uc744 \ud5a5\uc0c1\uc2dc\ud0b5\ub2c8\ub2e4.<br \/>\n*   \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \ubaa8\ub378\uc5d0 \ub300\ud55c \uae00\ub85c\ubc8c \uaddc\uc81c \uc2b9\uc778 \uac15\ud654 (CAGR\uc5d0 1.9% \uae30\uc5ec): \ubbf8\uad6d FDA\uc758 2024\ub144 \uac00\uc774\ub4dc\ub77c\uc778\uc740 \uc6d0\uaca9 \uc758\ub8cc \ubc29\ubb38, \uc9c0\uc5ed \uc758\ub8cc \uc804\ubb38\uac00 \ud65c\uc6a9, \ub514\uc9c0\ud138 \ub370\uc774\ud130 \uc218\uc6a9\uc5d0 \ub300\ud55c \uba85\ud655\uc131\uc744 \uc81c\uacf5\ud558\uc5ec \ud22c\uc790\ub97c \uc7a5\ub824\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. ICH E6(R3) \ubc0f EMA\uc758 \uc5c5\ub370\uc774\ud2b8\ub294 \uc8fc\uc694 \uc2dc\uc7a5 \uc804\ubc18\uc758 \uae30\ub300\ub97c \uc870\ud654\uc2dc\ud0a4\uace0 \uc788\uc73c\uba70, \uc2f1\uac00\ud3ec\ub974 HSA \ubc0f \ud638\uc8fc TGA\ub294 \uac04\uc18c\ud654\ub41c \uac80\ud1a0 \uacbd\ub85c\ub97c \uc81c\uacf5\ud558\uc5ec \ub2e4\uc9c0\uc5ed \ud655\uc7a5\uc131\uc744 \uc9c0\uc6d0\ud569\ub2c8\ub2e4.<br \/>\n*   \uc5f0\uacb0\ud615 \uc6e8\uc5b4\ub7ec\ube14 \ubc0f \ubc14\uc774\uc624\uc13c\uc11c \uae30\uc220 \ud655\uc0b0 (CAGR\uc5d0 1.6% \uae30\uc5ec): \uc758\ub8cc \ub4f1\uae09 \uc6e8\uc5b4\ub7ec\ube14\uc740 \uc778\uad6c \uaddc\ubaa8\uc5d0\uc11c \uc9c0\uc18d\uc801\uc774\uace0 \uac1d\uad00\uc801\uc778 \ud3c9\uac00 \uc9c0\ud45c\ub97c \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4. \uc774\ub294 \ucc38\uac00\uc790 \ubd80\ub2f4\uc744 \uc904\uc774\uace0 \ub370\uc774\ud130 \ubc00\ub3c4\ub97c \ub192\uc5ec \ud1b5\uacc4\uc801 \uac80\uc815\ub825\uc744 \ud5a5\uc0c1\uc2dc\ud0a4\uba70 \uc2e4\uc2dc\uac04 \uc548\uc804 \ubaa8\ub2c8\ud130\ub9c1\uc744 \uc9c0\uc6d0\ud569\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \ud569\uc131 \ub300\uc870\uad70 \ubc0f \uc608\uce21 \ubd84\uc11d\uc758 \ub4f1\uc7a5 (CAGR\uc5d0 1.4% \uae30\uc5ec): Phesi\uc758 Trial Accelerator Version 2\uc640 \uac19\uc740 \ub3c4\uad6c\ub294 \uc784\uc0c1\uc2dc\ud5d8 \uacc4\ud68d\uc790\uac00 \ub4f1\ub85d\uc744 \uc608\uce21\ud558\uace0 \ud3ec\ud568 \uae30\uc900\uc744 \ucd5c\uc801\ud654\ud560 \uc218 \uc788\ub3c4\ub85d \ub3d5\uc2b5\ub2c8\ub2e4. \ud569\uc131 \ub300\uc870\uad70\uc740 \uc885\uc591\ud559 \ubc0f \ud76c\uadc0 \uc9c8\ud658\uc5d0\uc11c \uc704\uc57d \ub178\ucd9c\uc5d0 \ub300\ud55c \uc724\ub9ac\uc801 \ubb38\uc81c\ub97c \uc644\ud654\ud558\uace0 \ubaa8\uc9d1 \uc694\uad6c \uc0ac\ud56d \ubc0f \ud0c0\uc784\ub77c\uc778 \uc704\ud5d8\uc744 \uc904\uc785\ub2c8\ub2e4.<br \/>\n*   \ube14\ub85d\uccb4\uc778 \uae30\ubc18 \ub3d9\uc758 \ubc0f \ub370\uc774\ud130 \ubb34\uacb0\uc131 \uc194\ub8e8\uc158 \ucc44\ud0dd (CAGR\uc5d0 0.8% \uae30\uc5ec): METORY\uc640 \uac19\uc740 \ube14\ub85d\uccb4\uc778 \ub3d9\uc801 \ub3d9\uc758 \uc2dc\uc2a4\ud15c\uc740 \ub192\uc740 \ub3d9\uc758 \uc644\ub8cc\uc728\uacfc \uc57d\ubb3c \uc21c\uc751\ub3c4\ub97c \ub2ec\uc131\ud588\uc2b5\ub2c8\ub2e4. Intel \ubc0f ConsenSys Health\uc758 \uc5f0\ud569 \uc544\ud0a4\ud14d\ucc98\ub294 \ud658\uc790 \ud504\ub77c\uc774\ubc84\uc2dc\ub97c \ubcf4\ud638\ud558\uba74\uc11c \uae30\uad00 \uac04 \ubd84\uc11d\uc744 \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4.<\/p>\n<p>\uc81c\uc57d \uc694\uc778<br \/>\n\uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc81c\uc57d \uc694\uc778\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc870\ud654\ub418\uc9c0 \uc54a\uc740 \uad6d\uc81c \ub370\uc774\ud130 \uac70\ubc84\ub10c\uc2a4 \ud504\ub808\uc784\uc6cc\ud06c \ubd80\uc871 (CAGR\uc5d0 -1.8% \uc601\ud5a5): GDPR, HIPAA \ubc0f \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc758 \ud604\uc9c0\ud654 \uaddc\uce59\uc73c\ub85c \uc778\ud574 \uc2a4\ud3f0\uc11c\ub294 \uc885\uc885 \ubcd1\ub82c \uc778\ud504\ub77c\ub97c \uad6c\ucd95\ud574\uc57c \ud558\uba70, \uc774\ub294 \uae00\ub85c\ubc8c DCT \ud50c\ub7ab\ud3fc\uc758 \uaddc\ubaa8 \uc774\uc810\uc744 \uc57d\ud654\uc2dc\ud0b5\ub2c8\ub2e4. \ub370\uc774\ud130 \uc8fc\uad8c\uc5d0 \ub300\ud55c \uc6b0\ub824\uc640 \uc0c1\uc774\ud55c \uac1c\uc778 \uc815\ubcf4 \ubcf4\ud638 \ubc95\uaddc\ub294 \ube44\uc6a9\uacfc \uc6b4\uc601 \ubcf5\uc7a1\uc131\uc744 \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4.<br \/>\n*   \uc0ac\uc774\ubc84 \ubcf4\uc548 \ubc0f \uac1c\uc778 \uc815\ubcf4 \ubcf4\ud638 \uaddc\uc815 \uc900\uc218 \uc704\ud5d8 \uc99d\uac00 (CAGR\uc5d0 -1.2% \uc601\ud5a5): \uc758\ub8cc \ubd80\ubb38\uc740 \ub2e4\ub978 \ubd80\ubb38\ubcf4\ub2e4 \uc0ac\uc774\ubc84 \uacf5\uaca9\uc5d0 \ub354 \ucde8\uc57d\ud558\uba70, DCT\ub294 \ud648 \ub124\ud2b8\uc6cc\ud06c \ubc0f \uac1c\uc778 \uc7a5\uce58\ub97c \ud1b5\ud574 \uc704\ud611 \ud45c\uba74\uc744 \ub113\ud799\ub2c8\ub2e4. FDA\uc758 2024\ub144 10\uc6d4 \uc804\uc790 \uc2dc\uc2a4\ud15c \uac00\uc774\ub4dc\ub77c\uc778\uc740 \uac10\uc0ac \ucd94\uc801 \ubc0f \uc704\ud5d8 \uae30\ubc18 \uac80\uc99d\uc744 \uc758\ubb34\ud654\ud558\uc5ec \uaddc\uc815 \uc900\uc218 \uc624\ubc84\ud5e4\ub4dc\ub97c \ucd94\uac00\ud569\ub2c8\ub2e4.<br \/>\n*   \uace0\ub839 \ubc0f \uc18c\uc678 \ud658\uc790 \ucf54\ud638\ud2b8 \uac04\uc758 \uae30\uc220 \uc811\uadfc\uc131 \uaca9\ucc28: \ub18d\ucd0c \uc9c0\uc5ed \ubc0f \uc800\uc18c\ub4dd\uce35 \uc9c0\uc5ed\uc5d0\uc11c\ub294 \uae30\uc220 \uc811\uadfc\uc131 \uaca9\ucc28\uac00 \uc5ec\uc804\ud788 \uc874\uc7ac\ud558\uc5ec DCT\uc758 \uad11\ubc94\uc704\ud55c \ucc44\ud0dd\uc744 \uc800\ud574\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uac00\uc815 \uae30\ubc18 \uac80\uccb4 \ucc44\ucde8\uc5d0 \ub300\ud55c \ubbf8\ud574\uacb0 \uc0c1\ud658 \ubc0f \ubb3c\ub958 \ubb38\uc81c: \ubd81\ubbf8 \ubc0f \uc720\ub7fd\uc744 \uc911\uc2ec\uc73c\ub85c \uac00\uc815 \uae30\ubc18 \uac80\uccb4 \ucc44\ucde8\uc5d0 \ub300\ud55c \uc0c1\ud658 \ubc0f \ubb3c\ub958 \ubb38\uc81c\uac00 \ud574\uacb0\ub418\uc9c0 \uc54a\uc544 DCT\uc758 \ud6a8\uc728\uc131\uc744 \uc800\ud574\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<br \/>\n*   \uc5f0\uad6c \uc124\uacc4\ubcc4: \uc911\uc7ac\uc801 \uc5f0\uad6c\ub294 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728 63.21%\ub85c \uc120\ub450\ub97c \ub2ec\ub9ac\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uad6c\uc870\ud654\ub41c \ud504\ub85c\ud1a0\ucf5c\uacfc \uc6d0\uaca9 \ub370\uc774\ud130 \ucea1\ucc98 \uac04\uc758 \uc77c\uce58\uc131, FDA \uac00\uc774\ub4dc\ub77c\uc778\uc758 \uc9c0\uc6d0\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. \ud655\ub300 \uc811\uadfc \ud504\ub85c\ud1a0\ucf5c\uc740 \ud658\uc790 \uc639\ud638 \ub2e8\uccb4\uc758 \ub178\ub825\uc73c\ub85c 15.89%\uc758 CAGR\ub85c \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uad6c\uc131 \uc694\uc18c\ubcc4: \ud074\ub77c\uc6b0\ub4dc \ud50c\ub7ab\ud3fc\uc740 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728 57.64%\ub85c, \uc548\uc804\ud55c \ub2e4\uc911 \uc774\ud574\uad00\uacc4\uc790 \uc811\uadfc, \uac10\uc0ac \uac00\ub2a5\uc131 \ubc0f \ud655\uc7a5 \uac00\ub2a5\ud55c \ubd84\uc11d\uc744 \uc9c0\uc6d0\ud569\ub2c8\ub2e4. \ud558\uc774\ube0c\ub9ac\ub4dc \ubc0f \uc571 \uc911\uc2ec \ud50c\ub7ab\ud3fc\uc740 \uc0ac\uc6a9\uc790 \uacbd\ud5d8\uc774 \ucc28\ubcc4\ud654 \uc694\uc18c\ub85c \ubd80\uc0c1\ud558\uba74\uc11c 16.48%\uc758 CAGR\ub85c \ud655\uc7a5\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \ubd84\uc57c\ubcc4: \uc885\uc591\ud559\uc740 2025\ub144 \uc2dc\uc7a5 \uaddc\ubaa8\uc758 45.72%\ub97c \ucc28\uc9c0\ud558\uba70, \ub192\uc740 \ubbf8\ucda9\uc871 \uc218\uc694\uc640 \ud658\uc790 \ubd80\ub2f4 \uc6b0\ub824\uac00 \uc8fc\uc694 \uc694\uc778\uc785\ub2c8\ub2e4. \uc2e0\uacbd\ud559\uc740 16.02%\uc758 CAGR\ub85c \uc131\uc7a5\ud558\uba70, \uc6e8\uc5b4\ub7ec\ube14\uc744 \ud65c\uc6a9\ud558\uc5ec \ubcf4\ud589, \uc218\uba74, \uc778\uc9c0 \uc9c0\ud45c\ub97c \uce21\uc815\ud558\ub294 \ub4f1 \ud604\uc7a5 \uc911\uc2ec \ubaa8\ub378\uc5d0\uc11c\ub294 \ubd88\uac00\ub2a5\ud588\ub358 \ub370\uc774\ud130\ub97c \uc218\uc9d1\ud569\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \uc81c\uc57d \ubc0f \ubc14\uc774\uc624\ud14d \uae30\uc5c5\uc740 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728 56.98%\ub85c \uc9c0\ubc30\uc801\uc774\uba70, R&#038;D \uc9d1\uc911\ub3c4\uc640 \ud2b9\ud5c8 \uc218\uba85 \uc8fc\uae30 \uc555\ub825\uc774 \uc8fc\uc694 \ub3d9\uc778\uc785\ub2c8\ub2e4. \uc758\ub8cc\uae30\uae30 \uc81c\uc870\uc5c5\uccb4\ub294 \uc6e8\uc5b4\ub7ec\ube14 \uac80\uc99d \ubc0f \uc2dc\ud310 \ud6c4 \uac10\uc2dc\uac00 \uc6d0\uaca9 \ubaa8\ub2c8\ud130\ub9c1\uacfc \uc790\uc5f0\uc2a4\ub7fd\uac8c \uc77c\uce58\ud558\uba74\uc11c 16.87%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \ubd80\ubb38\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed \ubd84\uc11d<br \/>\n*   \ubd81\ubbf8: 2025\ub144 \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc758 48.12%\ub97c \ucc28\uc9c0\ud558\uba70 \uc9c0\ubc30\uc801\uc778 \uc704\uce58\ub97c \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uac15\ub825\ud55c \uc6d0\uaca9 \uc758\ub8cc \uc0c1\ud658 \uc815\ucc45, FDA \uac00\uc774\ub4dc\ub77c\uc778, \ud48d\ubd80\ud55c \ubca4\ucc98 \uce90\ud53c\ud0c8 \uc720\uc785\uc5d0 \ud798\uc785\uc740 \uac83\uc785\ub2c8\ub2e4. Walgreens\uc640 BARDA\uc758 \uacc4\uc57d\uc740 \uc18c\uc678 \uc9c0\uc5ed\uc5d0 \ub3c4\ub2ec\ud558\uae30 \uc704\ud55c \uc18c\ub9e4 \uae30\ubc18 \uc784\uc0c1\uc2dc\ud5d8 \uc0dd\ud0dc\uacc4\uc758 \uc120\ub840\ub97c \ub9cc\ub4e4\uc5c8\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 15.32%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed\uc785\ub2c8\ub2e4. 30~40%\uc758 \ube44\uc6a9 \uc6b0\uc704\uc640 \ubbfc\ucca9\ud55c \uaddc\uc81c \uacbd\ub85c\uac00 \uc131\uc7a5\uc744 \uacac\uc778\ud569\ub2c8\ub2e4. \uc77c\ubcf8\uc758 \ub514\uc9c0\ud138 \ud5ec\uc2a4 \ucd94\uc9c4, \uc911\uad6d\uc758 \uaddc\uc81c \uac1c\ud601, \uc2f1\uac00\ud3ec\ub974 \ubc0f \ud638\uc8fc\uc758 DCT \uac00\uc774\ub4dc\ub77c\uc778\uc740 \ub2e4\uc9c0\uc5ed \ud504\ub85c\ud1a0\ucf5c\uc744 \uc6a9\uc774\ud558\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: EMA \uac00\uc774\ub4dc\ub77c\uc778\uacfc GDPR \uc900\uc218, \uadf8\ub9ac\uace0 \ub514\uc9c0\ud138 \ud5ec\uc2a4\ucf00\uc5b4 \uc774\ub2c8\uc154\ud2f0\ube0c\uac00 \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \ub3c4\uc785\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788, \uc720\ub7fd\uc5f0\ud569 \ub0b4 \uad6d\uac00 \uac04 \uaddc\uc81c \uc870\ud654 \ub178\ub825\uacfc \ud658\uc790 \uc811\uadfc\uc131 \ud5a5\uc0c1\uc5d0 \ub300\ud55c \uac15\uc870\ub294 \uc774 \uc9c0\uc5ed\uc758 \uc131\uc7a5\uc744 \ub354\uc6b1 \uac00\uc18d\ud654\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790<br \/>\n\ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc740 \uae30\uc220 \uc81c\uacf5\uc5c5\uccb4, CRO(\uc784\uc0c1\uc2dc\ud5d8\uc218\ud0c1\uae30\uad00), \uc81c\uc57d \ubc0f \ubc14\uc774\uc624 \uae30\uc5c5 \ub4f1 \ub2e4\uc591\ud55c \uc8fc\uccb4\ub4e4\uc774 \ucc38\uc5ec\ud558\uba70 \uacbd\uc7c1\uc774 \uc2ec\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc740 \uae30\uc220 \ud1b5\ud569, \ud30c\ud2b8\ub108\uc2ed \uad6c\ucd95, \uadf8\ub9ac\uace0 \uc0c8\ub85c\uc6b4 \uc11c\ube44\uc2a4 \ubaa8\ub378 \uac1c\ubc1c\uc744 \ud1b5\ud574 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, Medidata Solutions, IQVIA, Parexel, Labcorp, Oracle \ub4f1\uc740 \ud50c\ub7ab\ud3fc \uc194\ub8e8\uc158\uacfc \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud558\uba70 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub4e4\uc740 \uc6d0\uaca9 \ubaa8\ub2c8\ud130\ub9c1, \uc804\uc790 \ub3d9\uc758, \uac00\uc0c1 \ubc29\ubb38 \ub4f1 \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8\uc758 \ud575\uc2ec \uc694\uc18c\ub97c \uc9c0\uc6d0\ud558\ub294 \uae30\uc220\uc744 \uc9c0\uc18d\uc801\uc73c\ub85c \ubc1c\uc804\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacb0\ub860<br \/>\n\ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc740 \uae30\uc220 \ubc1c\uc804, \uaddc\uc81c \uc9c0\uc6d0, \uadf8\ub9ac\uace0 \ud658\uc790 \uc911\uc2ec\uc758 \uc758\ub8cc \ud328\ub7ec\ub2e4\uc784 \uc804\ud658\uc5d0 \ud798\uc785\uc5b4 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788, \ud32c\ub370\ubbf9 \uc774\ud6c4 \uc6d0\uaca9 \uc758\ub8cc\uc640 \ub514\uc9c0\ud138 \ud5ec\uc2a4\ucf00\uc5b4\uc758 \uc911\uc694\uc131\uc774 \ubd80\uac01\ub418\uba74\uc11c \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8\uc740 \uc784\uc0c1 \uc5f0\uad6c\uc758 \ud6a8\uc728\uc131\uc744 \ub192\uc774\uace0 \ud658\uc790 \uc811\uadfc\uc131\uc744 \uac1c\uc120\ud558\ub294 \ud575\uc2ec\uc801\uc778 \ubc29\ubc95\uc73c\ub85c \uc790\ub9ac\ub9e4\uae40\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc55e\uc73c\ub85c\ub3c4 \uc778\uacf5\uc9c0\ub2a5, \ube45\ub370\uc774\ud130, \uc6e8\uc5b4\ub7ec\ube14 \uae30\uae30 \ub4f1\uc758 \uae30\uc220\uc774 \ub354\uc6b1 \ubc1c\uc804\ud568\uc5d0 \ub530\ub77c \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8\uc740 \ub354\uc6b1 \uc815\uad50\ud558\uace0 \uad11\ubc94\uc704\ud558\uac8c \ud65c\uc6a9\ub420 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8(Decentralized Clinical Trials, DCT) \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \ubcf4\uace0\uc11c\uc5d0 \ub530\ub974\uba74, \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc740 \ud658\uc790, \uc5f0\uad6c\uc790 \ub610\ub294 \ubaa8\ub2c8\ud130\uac00 \uc6d0\uaca9\uc73c\ub85c \uc784\uc0c1\uc2dc\ud5d8 \uc5c5\ubb34\ub97c \uc218\ud589\ud560 \uc218 \uc788\ub3c4\ub85d \uc9c0\uc6d0\ud558\ub294 \ubaa8\ub4e0 \uae30\uc220 \ubc0f \uc11c\ube44\uc2a4(\ud074\ub77c\uc6b0\ub4dc \ud50c\ub7ab\ud3fc, \uc804\uc790 \ub3d9\uc758(eConsent), \uc5f0\uacb0\ud615 \uc6e8\uc5b4\ub7ec\ube14 \uae30\uae30, \uc7ac\ud0dd \uac04\ud638, \ud658\uc790 \uc9c1\uc811 \ubc30\uc1a1 \ubb3c\ub958 \ub4f1)\ub97c \ud3ec\ud568\ud558\uba70, \uc804 \uc138\uacc4 \ubaa8\ub4e0 \uc784\uc0c1 \ub2e8\uacc4, \uc5f0\uad6c \uc124\uacc4 \ubc0f \uce58\ub8cc \uc601\uc5ed\uc744 \uc544\uc6b0\ub985\ub2c8\ub2e4. \uc77c\ubc18\uc801\uc778 \uc6d0\uaca9 \uc758\ub8cc \uc18c\ud504\ud2b8\uc6e8\uc5b4 \ubc0f \uaddc\uc81c\ub41c \uc784\uc0c1\uc2dc\ud5d8 \ud504\ub85c\ud1a0\ucf5c\uacfc \uad00\ub828 \uc5c6\ub294 \uc77c\uc0c1\uc801\uc778 \ud0dd\ubc30 \uc11c\ube44\uc2a4\ub294 \ubc94\uc704\uc5d0\uc11c \uc81c\uc678\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd\uc5d0 \ub530\ub974\uba74, \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc740 2026\ub144 107\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2031\ub144\uae4c\uc9c0 210\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\ub825\uc73c\ub85c\ub294 \uc6d0\uaca9 \uc758\ub8cc \ubc0f \uc6d0\uaca9 \ud658\uc790 \ubaa8\ub2c8\ud130\ub9c1 \uc778\ud504\ub77c\uc758 \ud655\uc7a5, \ud6a8\uc728\uc131 \uc99d\ub300 \ubc0f \uc5f0\uad6c \uae30\uac04 \ub2e8\ucd95, \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \ubaa8\ub378\uc5d0 \ub300\ud55c \uae00\ub85c\ubc8c \uaddc\uc81c \uc2b9\uc778 \uac15\ud654, \uc5f0\uacb0\ud615 \uc6e8\uc5b4\ub7ec\ube14 \ubc0f \ubc14\uc774\uc624\uc13c\uc11c \uae30\uc220\uc758 \ud655\uc0b0, AI \uae30\ubc18 \ud569\uc131 \ub300\uc870\uad70 \ubc0f \uc608\uce21 \ubd84\uc11d\uc758 \ub4f1\uc7a5, \ube14\ub85d\uccb4\uc778 \uae30\ubc18 \ub3d9\uc758 \ubc0f \ub370\uc774\ud130 \ubb34\uacb0\uc131 \uc194\ub8e8\uc158 \ucc44\ud0dd \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \uad6d\uc81c \ub370\uc774\ud130 \uac70\ubc84\ub10c\uc2a4 \ud504\ub808\uc784\uc6cc\ud06c\uc758 \uc870\ud654 \ubd80\uc871, \uc0ac\uc774\ubc84 \ubcf4\uc548 \ubc0f \uac1c\uc778 \uc815\ubcf4 \ubcf4\ud638 \uaddc\uc815 \uc900\uc218 \uc704\ud5d8 \uc99d\uac00, \uace0\ub839 \ubc0f \uc18c\uc678\ub41c \ud658\uc790 \uc9d1\ub2e8 \uac04\uc758 \uae30\uc220 \uc811\uadfc\uc131 \uaca9\ucc28, \uc7ac\ud0dd \uac80\uccb4 \uc218\uc9d1\uc5d0 \ub300\ud55c \ubbf8\ud574\uacb0\ub41c \uc0c1\ud658 \ubc0f \ubb3c\ub958 \ubb38\uc81c \ub4f1\uc774 \uc9c0\uc801\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc740 \uc5f0\uad6c \uc124\uacc4, \uad6c\uc131 \uc694\uc18c, \uce58\ub8cc \ubd84\uc57c, \ucd5c\uc885 \uc0ac\uc6a9\uc790 \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \ubd84\uc11d\ub429\ub2c8\ub2e4.<br \/>\n*   \uc5f0\uad6c \uc124\uacc4\ubcc4: \uc911\uc7ac \uc5f0\uad6c(Interventional trials)\uac00 63.21%\uc758 \uc810\uc720\uc728\ub85c \uac00\uc7a5 \uc9c0\ubc30\uc801\uc774\uba70, \uc6d0\uaca9 \ubaa8\ub2c8\ud130\ub9c1 \ubc0f \uad6c\uc870\ud654\ub41c \ud3c9\uac00 \ubcc0\uc218\uc640\uc758 \ud638\ud658\uc131\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4.<br \/>\n*   \uad6c\uc131 \uc694\uc18c\ubcc4: \ud074\ub77c\uc6b0\ub4dc \uae30\ubc18 \ud50c\ub7ab\ud3fc\uc774 \ud655\uc7a5\uc131\uacfc \uaddc\uc815 \uc900\uc218 \uc5ed\ub7c9 \ub355\ubd84\uc5d0 57.64%\uc758 \uc810\uc720\uc728\ub85c \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud569\ub2c8\ub2e4. \uc6f9 \uae30\ubc18 \ubc0f \ud558\uc774\ube0c\ub9ac\ub4dc\/\uc571 \uc911\uc2ec \ud50c\ub7ab\ud3fc\ub3c4 \ud3ec\ud568\ub429\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \ubd84\uc57c\ubcc4: \uc885\uc591\ud559, \uc2ec\uc7a5\ud559, \uc2e0\uacbd\ud559, \ud638\ud761\uae30 \uc9c8\ud658 \ubc0f \uae30\ud0c0 \uce58\ub8cc \ubd84\uc57c\uac00 \uc8fc\uc694 \ubd84\uc11d \ub300\uc0c1\uc785\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \uc2a4\ud3f0\uc11c, \uc758\ub8cc\uae30\uae30 \uc81c\uc870\uc5c5\uccb4, \uc784\uc0c1\uc2dc\ud5d8\uc218\ud0c1\uae30\uad00(CRO), \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00\uc774 \uc8fc\uc694 \ucd5c\uc885 \uc0ac\uc6a9\uc790\uc785\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8\uac00 \uac15\ub825\ud55c \uc6d0\uaca9 \uc758\ub8cc \uc778\ud504\ub77c\uc640 FDA\uc758 \uc9c0\uc6d0\uc801\uc778 \uc9c0\uce68\uc5d0 \ud798\uc785\uc5b4 48.12%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\ub85c \uc120\ub450\ub97c \ub2ec\ub9ac\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \ube44\uc6a9 \uc774\uc810\uacfc \uac04\uc18c\ud654\ub41c \uaddc\uc81c\ub85c \uc778\ud574 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 15.32%\uc758 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc720\ub7fd, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8 \uc9c0\uc5ed\ub3c4 \ud3ec\ud568\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc740 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d \ubc0f Advarra, Thermo Fisher Scientific, IQVIA Inc., Dassault Syst\u00e8mes, Clario, Oracle (Health Sciences), ICON plc, Labcorp Drug Development, Parexel, Syneos Health, Science 37, Medable \ub4f1 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \ud504\ub85c\ud544\uc744 \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\uc758 \uc5f0\uad6c \ubc29\ubc95\ub860\uc740 1\ucc28 \uc5f0\uad6c(CRO \uc6b4\uc601 \ucc45\uc784\uc790, \ud50c\ub7ab\ud3fc \uc81c\ud488 \uad00\ub9ac\uc790, \ud604\uc7a5 \uac04\ud638\uc0ac \ub4f1\uacfc\uc758 \uc778\ud130\ubdf0 \ubc0f \uc124\ubb38\uc870\uc0ac)\uc640 2\ucc28 \uc5f0\uad6c(FDA, EMA \ub4f1\ub85d, ClinicalTrials.gov, \uae30\uc5c5 \uacf5\uc2dc \uc790\ub8cc \ub4f1)\ub97c \uacb0\ud569\ud569\ub2c8\ub2e4. \uc2dc\uc7a5 \uaddc\ubaa8 \uc0b0\uc815 \ubc0f \uc608\uce21\uc740 \uc0c1\ud5a5\uc2dd \ubc0f \ud558\ud5a5\uc2dd \uc811\uadfc \ubc29\uc2dd\uc744 \ubaa8\ub450 \uc0ac\uc6a9\ud558\uc5ec \uc9c4\ud589\ub418\uba70, \ub2e4\ubcc0\ub7c9 \ud68c\uadc0 \ubd84\uc11d\uacfc \uc2dc\ub098\ub9ac\uc624 \ubd84\uc11d\uc744 \ud1b5\ud574 \uaddc\uc81c \ub610\ub294 \ube44\uc6a9 \ucda9\uaca9\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. \ub370\uc774\ud130\ub294 \uc678\ubd80 \uc9c0\ud45c\uc640 \ube44\uad50\ud558\uc5ec \uac80\uc99d\ub418\uba70, \ub9e4\ub144 \uc5c5\ub370\uc774\ud2b8\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacb0\ub860\uc801\uc73c\ub85c, \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \uc2dc\uc7a5\uc740 \uae30\uc220 \ubc1c\uc804\uacfc \uaddc\uc81c \uc9c0\uc6d0\uc5d0 \ud798\uc785\uc5b4 \uc0c1\ub2f9\ud55c \uc131\uc7a5\uc744 \uc9c0\uc18d\ud560 \uac83\uc774\ub098, \uad6d\uc81c \ub370\uc774\ud130 \uac70\ubc84\ub10c\uc2a4 \uc870\ud654 \ubd80\uc871\uacfc \uac19\uc740 \uacfc\uc81c \ud574\uacb0\uc774 \uc2dc\uc7a5 \ud655\uc0b0\uc5d0 \uc911\uc694\ud55c \uc694\uc18c\ub85c \uc791\uc6a9\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-28140","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/28140"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=28140"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/28140\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=28140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=28140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=28140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}